Cameron Pitt
Founder at Quanta Therapeutics, Inc.
Cameron Pitt active positions
| Companies | Position | Start | End |
|---|---|---|---|
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Director/Board Member | 2017-12-31 | - |
| Founder | 2017-12-31 | - | |
| Corporate Officer/Principal | 2017-12-31 | - |
Career history of Cameron Pitt
Former positions of Cameron Pitt
| Companies | Position | Start | End |
|---|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Analyst | 2017-12-31 | 2020-04-29 |
Training of Cameron Pitt
| University of California | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Private Equity Analyst | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Cameron Pitt
- Experience
